A new test for analyzing the chromosomes of stillborn babies, known as microarray analysis, has now proven 40 percent more effective in pinpointing potential genetic causes of death than the old karyotype testing procedure. Researchers at UTMB, along with a team of other national leaders in maternal-fetal medicine, have published their findings in the Dec. 6 issue of the New England Journal of Medicine. “Families have a much greater sense of closure if they understand what likely caused their baby to die,” said Dr. George Saade, lead investigator of the UTMB arm of the study. “And for doctors to be able to see more genetic information about each stillborn baby can only be a good thing in terms of continuing the fight to reduce stillbirths worldwide.”